发明授权
- 专利标题: Substituted benzimidazoles and their use for inducing apoptosis
- 专利标题(中): 取代的苯并咪唑及其诱导凋亡的用途
-
申请号: US11501648申请日: 2006-08-09
-
公开(公告)号: US07423157B2公开(公告)日: 2008-09-09
- 发明人: Martin Eberle , Felix Bachmann , Alessandro Strebel , Subho Roy , Sudhir Srivastava , Goutam Saha
- 申请人: Martin Eberle , Felix Bachmann , Alessandro Strebel , Subho Roy , Sudhir Srivastava , Goutam Saha
- 申请人地址: CH Basel
- 专利权人: Basilea Pharmaceutica AG
- 当前专利权人: Basilea Pharmaceutica AG
- 当前专利权人地址: CH Basel
- 优先权: EP04405082 20040211
- 主分类号: C07D403/04
- IPC分类号: C07D403/04
摘要:
The invention relates to compounds of formula (I) wherein R represents aryl or heteroaryl, X is a bond, a carbonyl group, a derivative of a carbonyl group, an ethylene group or an ethylenecarbonyl group, R1 is optionally substituted amino or hydroxy, and the substituents R2 to R6 have the meanings given in the specification, to methods of synthesis of such compounds, to pharmaceutical compositions containing compounds of formula (I), to intermediates, to the use of a compounds of formula (I) as a medicament and for the preparation of a pharmaceutical composition for the treatment of neoplastic and autoimmune diseases, and to methods of treatment of neoplastic and autoimmune diseases using such compounds of formula (I) or of pharmaceutical compositions containing same.
公开/授权文献
信息查询